SOX9 and ovarian cancer: Further mechanistic studies indicate that targeted inhibition of USP28 using a specific inhibitor leads to ubiquitination-mediated degradation of SOX9, consequently inhibiting DNA damage repair capabilities, and ultimately enhancing the sensitivity of ovarian cancer to PARPi.